These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2855851)

  • 21. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
    Koek W; Woods JH; Jacobson AE; Rice KC; Lessor RA
    J Pharmacol Exp Ther; 1986 May; 237(2):386-92. PubMed ID: 3009781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain.
    Loo PA; Braunwalder AF; Williams M; Sills MA
    Eur J Pharmacol; 1987 Mar; 135(2):261-3. PubMed ID: 3034630
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification and properties of phencyclidine-binding sites in nervous tissues.
    Vincent JP; Bidard JN; Lazdunski M; Romey G; Tourneur Y; Vignon J
    Fed Proc; 1983 Jun; 42(9):2570-3. PubMed ID: 6303860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phencyclidine receptors in rat brain cortex.
    Mendelsohn LG; Kerchner GA; Kalra V; Zimmerman DM; Leander JD
    Biochem Pharmacol; 1984 Nov; 33(22):3529-35. PubMed ID: 6095851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophilic affinity ligands for the phencyclidine (PCP) receptor.
    Lessor RA; Mattson MV; Rice KC; Jacobson AE
    NIDA Res Monogr; 1986; 67():138-44. PubMed ID: 3018571
    [No Abstract]   [Full Text] [Related]  

  • 26. The rat brain phencyclidine (PCP) receptor. A putative K+ channel.
    Sorensen RG; Blaustein MP
    Biochem Pharmacol; 1988 Feb; 37(3):511-9. PubMed ID: 2447895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of phencyclidine with crayfish muscle membranes. Sensitivity to calcium channel antagonists and other drugs.
    El-Fakahany EE; Eldefrawi AT; Murphy DL; Aguayo LG; Triggle DJ; Albuquerque EX; Eldefrawi ME
    Mol Pharmacol; 1984 May; 25(3):369-78. PubMed ID: 6328263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and characterization of a radiolabelled derivative of the phencyclidine/N-methyl-D-aspartate receptor ligand (+) MK-801 with high specific radioactivity.
    Keana JF; Scherz MW; Quarum M; Sonders MS; Weber E
    Life Sci; 1988; 43(12):965-73. PubMed ID: 2845205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship studies of phencyclidine derivatives in rats.
    Cone EJ; McQuinn RL; Shannon HE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):147-53. PubMed ID: 6694098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
    Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The competitive NMDA receptor antagonist, CPP, allosterically modulates NMDA receptor associated PCP binding sites in the absence of steric hinderance.
    Reid AA; Bowen WD; Setterlund C; Rothman RB
    NIDA Res Monogr; 1990; 105():339-40. PubMed ID: 1678869
    [No Abstract]   [Full Text] [Related]  

  • 32. Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline.
    Jamieson GA; Agrawal AK; Greco NJ; Tenner TE; Jones GD; Rice KC; Jacobson AE; White JG; Tandon NN
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):35-9. PubMed ID: 1322125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.
    Gray NM; Cheng BK; Mick SJ; Lair CM; Contreras PC
    J Med Chem; 1989 Jun; 32(6):1242-8. PubMed ID: 2542555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etoxadrol-meta-isothiocyanate: a potent, enantioselective, electrophilic affinity ligand for the phencyclidine-binding site.
    Thurkauf A; Mattson MV; Huguenin PN; Rice KC; Jacobson AE
    FEBS Lett; 1988 Oct; 238(2):369-74. PubMed ID: 2901991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for an endogenous peptide ligand and antagonist for PCP receptors.
    Contreras PC; DiMaggio DA; O'Donohue TL
    Prog Clin Biol Res; 1985; 192():495-8. PubMed ID: 3001770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroencephalographic (EEG), psychopharmacological, and receptor-binding profiles of 'phencyclinoids'.
    Mattia A; Leccese AP; Marquis KL; el-Fakahany EE; Moreton JE
    NIDA Res Monogr; 1986; 64():94-111. PubMed ID: 3012348
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A specific acylating agent for the [3H]phencyclidine receptors in rat brain.
    Rafferty MF; Mattson M; Jacobson AE; Rice KC
    FEBS Lett; 1985 Feb; 181(2):318-22. PubMed ID: 2982662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of metaphit on phencyclidine and serotonin2 receptors.
    Nabeshima T; Tohyama K; Noda A; Maeda Y; Hiramatsu M; Harrer SM; Kameyama T; Furukawa H; Jacobson AE; Rice KC
    Neurosci Lett; 1989 Jul; 102(2-3):303-8. PubMed ID: 2554211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of phencyclidine, etoxadrol and dexoxadrol in the pigeon.
    Leander JD
    Subst Alcohol Actions Misuse; 1982; 3(4):197-203. PubMed ID: 6132451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.